Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Yesafili (aflibercept-jbvf), an Interchangeable Biosimilar to Eylea

The U.S. Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept...

FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea

The U.S. Food and Drug Administration (FDA) has approved Opuviz (aflibercept-yszy), an interchangeable biosimilar to Eylea (aflibercept). Aflibercept...

FDA Approves Benlysta (belimumab) Autoinjector for Children with Systemic Lupus Erythematosus

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg subcutaneous route of administration of Benlysta...

FDA Grants Accelerated Approval for Imdelltra (tarlatamab-dlle) for the Treatment of Extensive-Stage Small Cell Lung Cancer

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Imdelltra™ (tarlatamab-dlle) for the treatment...

Offering Choice of CRC Screening Increases Completion Rates

For adults who are not up to date with colorectal cancer screening, offering a choice of colonoscopy or fecal immunochemical testing (FIT) increases screening...

Physical Activity Time, Step Counts Yield Similar Results

Moderate-to-vigorous physical activity (MVPA) time and step counts are similarly associated with all-cause mortality and cardiovascular disease, according...

Nonwhite Adults With Cognitive Impairment More Likely to Live in Polluted Areas

Nonwhite adults with mild cognitive impairment (MCI) are more likely to live in areas with higher pollution, according to a study published online May...

Acrochordons May Be Marker for Metabolic Disease in Children

In pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric Dermatology.Rachel...

GSK Announces Positive Results from Phase III Severe Asthma Trials of Depemokimab

GSK plc (LSE/NYSE: GSK) today announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and...

Cannabis Edibles Are Triggering Poisonings Among Older Users

The legalization of cannabis and the popularity of its edible versions is having an unexpected effect: More seniors landing in emergency departments with...

A Matcha Mouthwash Might Fight Gum Disease

Matcha green tea has the potential to keep gum disease at bay, a new study finds. Lab experiments show that matcha can inhibit the growth of Porphyromonas...

'Hungry Gut' Gene Test Shows Who'll Benefit Most From Wegovy

You've watched others shed pounds in a matter of weeks after taking one of the new blockbuster weight-loss drugs, so you decide to try one of the medications...

Vaping After Quitting Smoking Keeps Lung Cancer Risk High

If you've quit smoking and have switched to vaping instead, your odds for lung cancer won't fall as steeply as if you quit nicotine altogether, new research...

Zymfentra demonstrated long-term efficacy and safety profile of maintenance treatment for adults with moderately to severely active Crohn's disease and ulcerative colitis

JERSEY CITY, N.J., May 21, 2024. Celltrion USA announced today positive two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC)...

Does It Matter What You Eat or Drink Before Bed?

If you suddenly find yourself craving food or drink right before you head to bed, one expert suggests you steer clear of big meals and caffeine. "From...

Cross-Compatibility Issues with Autoinjector Devices Optional for Use with Glatiramer Acetate Injection

FDA is alerting patients, caregivers, and health care professionals of labeling updates for glatiramer acetate injection products. Updated labeling includes...

Plant-Based Diets Tied to Long-Term Health Benefits

Plant-based diets appear beneficial in lowering cardiometabolic risk factors, as well as cardiovascular diseases (CVDs), cancer risk, and mortality, according...

Read more news...

Recently Added

Recently added consumer and prescribing information: Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Yesafili Yesafili (aflibercept-jbvf) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
  • Opuviz Opuviz (aflibercept-yszy) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
  • Imdelltra Imdelltra (tarlatamab-dlle) is a first-in-class, bispecific delta-like ligand 3 (DLL3)-directed CD3 T cell engager indicated for the...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development